SCHEMBL17065838

SCHEMBL17065838

CCN(CC)c1c(Br)c(OC)cc2ccccc12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NQO1 P15559 1/20 0.40
MAPT P10636 4/20 0.39
SMN1; SMN2 Q16637 3/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
ALDH1A1 P00352 3/20 0.37
HPGD P15428 2/20 0.37
KDM4E B2RXH2 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
HIF1A Q16665 2/20 0.36
GAA P10253 1/20 0.36
BCHE P06276 1/20 0.36
ACHE P22303 1/20 0.36
LMNA P02545 1/20 0.36
NSD2 O96028 1/20 0.35
CASP6 P55212 1/20 0.35
TP53 P04637 1/20 0.35
CYP1A2 P05177 1/20 0.35
BRCA1 P38398 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17065818 0.78 TRPM4 (0.43) MAPTSMN1; SMN2NPC1RAB9AALDH1A1
SCHEMBL17065826 0.77 KDM4E (0.43) MAPTSMN1; SMN2ALDH1A1HPGDKDM4E
SCHEMBL11347674 0.76 L3MBTL1 (0.43) ALDH1A1HPGDKDM4EL3MBTL1HIF1A
SCHEMBL5460840 0.74 NQO1 (0.47) NQO1MAPTSMN1; SMN2NPC1ALDH1A1
SCHEMBL19617285 0.70 ALDH1A1 (0.47) NQO1MAPTSMN1; SMN2ALDH1A1HPGD
SCHEMBL17065828 0.70 MAPT (0.41) MAPTSMN1; SMN2NPC1RAB9AALDH1A1
SCHEMBL30065634 0.70 ALDH1A1 (0.47) NQO1MAPTSMN1; SMN2ALDH1A1HPGD
SCHEMBL13302148 0.70 PTGES (0.48) NQO1MAPTSMN1; SMN2NPC1ALDH1A1
SCHEMBL6345611 0.69 ALDH1A1 (0.46) NQO1MAPTNPC1RAB9AALDH1A1
SCHEMBL25992583 0.69 MAPT (0.52) NQO1MAPTSMN1; SMN2ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3113768-A1 USE OF ARYLALKANOLAMINES AS SIGMA-1 RECEPTOR ANTAGONISTS Universita' Degli Studi Di Pavia (IT) 2017-01-11 EP disclosed
WO-2015132733-A1 USE OF ARYLALKANOLAMINES AS SIGMA-1 RECEPTOR ANTAGONISTS UNIVERSITA' DEGLI STUDI DI PAVIA (IT) 2015-09-11 WO disclosed